Bronx, NY, United States of America

Keith Everett Maier

This inventor holds 1 USPTO granted patent. Top assignee: Albert Einstein College of Medicine. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keith Everett Maier. Retrieved from https://idiyas.com/inventor/keith-everett-maier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keith Everett Maier: Innovator in Aptamer Technology

Introduction

Keith Everett Maier is a notable inventor based in the Bronx, NY. He has made significant contributions to the field of aptamer technology, particularly in the development of targeted drug delivery systems. His work focuses on enhancing the efficacy of treatments through innovative methods.

Latest Patents

Maier holds a patent for "Transferrin receptor aptamers and aptamer-targeted delivery." This patent involves aptamers that target the human transferrin receptor without competing with transferrin for binding. The invention also includes compositions and methods for aptamer-targeted liposomal drug delivery, showcasing his commitment to advancing medical technology.

Career Highlights

Keith Maier is affiliated with the Albert Einstein College of Medicine, where he continues to push the boundaries of research in his field. His work has garnered attention for its potential applications in medicine and drug delivery systems.

Collaborations

Maier collaborates with esteemed colleagues, including Matthew Levy and Samantha E. Wilner, contributing to a dynamic research environment that fosters innovation.

Conclusion

Keith Everett Maier's contributions to aptamer technology and drug delivery systems highlight his role as a leading inventor in the medical research community. His innovative work continues to pave the way for advancements in targeted therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…